| 09:00-10:30 |
Microbiome, Urological disease, and Biological therapeutics |
|
| |
|
Vaginal microbiome and recurrent cystitis |
|
| Urinary microbiome, OAB and IC/PBS |
|
| Cancer immunotherapy with probiotics for urothelial carcinoma in Kagoshima university |
|
| Microbiome and biological therapeutics: Phage therapy |
|
| Panel Discussion |
|
| |
| 10:30-11:00 |
Coffee Break |
|
| 11:00-12:30 |
Voiding Dysfunction I: Advanced Clinical Practice: Botulinum toxin A Intradetrusor Injection Mastery |
|
| |
|
Unlocking the Power: Botox's Mechanisms in Overactive Bladder Treatment |
|
| Optimizing Patient Care: Enhancing Bladder Function Assessment for Procedural Success |
|
| Precision and Safety: Expert Strategies for Perfecting Injection Technique |
|
| Navigating Treatment Challenges: Effective Strategies for Refractory Cases |
|
| Panel Discussion |
|
| |
| 12:30-13:30 |
Lunch |
|
| 13:30-14:30 |
Urological Oncology III: Urothelial |
|
| |
|
Merging urinary biomarkers for the detection and surveillance of urothelial carcinoma |
|
| Impact of Artificial Intelligence on practices for urological malignancy |
|
| Novel antibody-drug conjugates (ADC) and combination therapy in urothelial carcinoma |
|
| Panel Discussion |
|
| |
| 14:30-15:30 |
Prostate II: Biochemical recurrence after primary definitive therapy |
|
| |
|
Treatment options for BCR |
|
| After Radical prostatectomy |
|
| After External Beam Radiation Therapy |
|
| Panel Discussion |
|
| |
| 15:30-16:00 |
Coffee Break |
|
| 16:00-17:30 |
Endourology & Robotics II |
|
| |
|
Oral chemolytic therapy for renal stone: Myth and Truth |
|
| Clinical experience of RIRS under local anesthesia |
|
| Tips and Tricks of supine ECIRS for complicated renal stones |
|
| Clinical experience of novel robot-assisted RIRS |
|
| Panel Discussion |
|
| |
